In nanoparticle (NP)-mediated drug delivery, liposomes are the most widely used drug
carrier, and the only NP system currently approved by the FDA for clinical use, owing to their …

Ruthenium (II) and iridium (III) coordination compounds display excellent structural,
photophysical, and biological properties which make them highly promising as anticancer …

Mitochondrial dysfunction is an early event of Alzheimer's disease (AD), contributes the
onset and progression of AD, and may represent an effective therapeutic target for AD …

More than 10 million death tolls in 2020 were reported as a result of heinous impact of
cancer, making it second most prime cause of death after cardiovascular diseases. In …

Research into cancer therapeutics has uncovered various potential medications based on
metal-containing scaffolds after the discovery and clinical applications of cisplatin as an anti …

Platinum-based anticancer drugs currently available in the market are associated with
severe side effects. Therefore, extensive research has been performed to design and …

In this work, we have synthesized a series of novel C, N-cyclometalated 2 H-indazole-
ruthenium (II) and-iridium (III) complexes with varying substituents (H, CH3, isopropyl, and …

Metal complexes are of increasing interest as pharmaceutical agents in cancer diagnostics
and therapeutics, while some of them suffer from issues such as limited water solubility and …

Moringa oleifera leaf polyphenols (Mopp) were encapsulated with phytosomes to enhance
their efficacy on 4T1 cancer cell lines. The Mopp were extracted via microwave-assisted …

The need to synthesize an effective anticancer drug with minimal side effects has been the
aim and concern of the researchers around the world. Cytotoxicity and selectivity are the two …